Research Compounds

NNMT (nicotinamide N-methyltransferase) inhibitor studied for its effects on adipogenesis, energy expenditure, and NAD+ pathway modulation in metabolic research.

ActRIIB-Fc decoy receptor studied for myostatin and GDF-11 inhibition pathway research. Investigated in muscular dystrophy and sarcopenia preclinical models.

Prohibitin-targeting peptide studied for proapoptotic effects on white adipose tissue vasculature in preclinical obesity research models.

C-terminal fragment of hGH (177–191) studied for lipolytic signaling without IGF-1 axis activation in metabolic and adipogenesis research.

Activin-binding glycoprotein studied for myostatin inhibition, FSH suppression, and muscle fiber hypertrophy signaling in musculoskeletal research.

D-retro-inverso FOXO4 peptide studied for selective senescent cell apoptosis induction (senolysis) in aging and lifespan extension research models.

Nicotinamide adenine dinucleotide studied for mitochondrial function, sirtuin pathway activation, DNA repair, and cellular energy metabolism in aging research.

ERR (estrogen-related receptor) agonist studied for mitochondrial biogenesis, exercise mimicry, and metabolic pathway activation in longevity and fitness research.

Mitochondria-targeted peptide studied for oxidative stress reduction, mitochondrial membrane protection, and cardioprotective signaling in aging and metabolic research.

Methylcobalamin form of B12 studied for methylation pathway support, neurological function, homocysteine regulation, and energy metabolism research.